| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |